Mogrify Company
![](/files/companies/Mogrify.png)
Mogrify is transforming the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.
Investors
Founded Date:
2016
Estimated Revenue:
$1M to $10M
Employee Number:
11-50
Industry:
Cell therapy
Technology:
Intelligent Data Analysis
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Funding Status:
Early Stage Venture